|
Capture |
1 |
|
L1_De Neve_Introduction |
2 |
|
L2_Peschke_Clinical Radiation Biology |
28 |
|
L4_Schippers_Particle generation |
86 |
|
Slide Number 1 |
86 |
|
Slide Number 2 |
87 |
|
Slide Number 3 |
88 |
|
Slide Number 4 |
89 |
|
Slide Number 5 |
90 |
|
Slide Number 6 |
91 |
|
Slide Number 7 |
92 |
|
Slide Number 8 |
93 |
|
Slide Number 9 |
94 |
|
Slide Number 10 |
95 |
|
Slide Number 11 |
96 |
|
Slide Number 12 |
97 |
|
Slide Number 13 |
98 |
|
Pencil beam scanning |
99 |
|
Slide Number 15 |
100 |
|
Slide Number 16 |
101 |
|
Slide Number 17 |
102 |
|
Slide Number 18 |
103 |
|
Slide Number 19 |
104 |
|
Slide Number 20 |
105 |
|
Slide Number 21 |
106 |
|
Slide Number 22 |
107 |
|
Slide Number 23 |
108 |
|
Slide Number 24 |
109 |
|
Slide Number 25 |
110 |
|
Slide Number 26 |
111 |
|
Slide Number 27 |
112 |
|
Slide Number 28 |
113 |
|
Slide Number 29 |
114 |
|
Slide Number 30 |
115 |
|
Slide Number 31 |
116 |
|
Slide Number 32 |
117 |
|
Slide Number 33 |
118 |
|
Slide Number 34 |
119 |
|
Slide Number 35 |
120 |
|
L6_Habrand_PT Rationale |
121 |
|
L8_Fossati_Carbon Ion RT at NIRS and CNAO |
162 |
|
L9_Lomax_Active beam delivery and IMPT |
190 |
|
L10_Jäkel_ETC RBE |
228 |
|
L11_Fossati_Prescribing&reportingCIT |
252 |
|
L12_Peschke_New biological insights in hypofract |
314 |
|
L14_Habrand_Modern PT for pediatric cancers |
358 |
|
L15_Hug_Lung cancer |
399 |
|
L16_Krengli_Prostate |
461 |
|
L17_Lomax_Image guidance |
511 |
|
L18_Schippers_New technologies |
539 |
|
Slide Number 1 |
539 |
|
Slide Number 2 |
540 |
|
Slide Number 3 |
541 |
|
Slide Number 4 |
542 |
|
Slide Number 5 |
543 |
|
Slide Number 6 |
544 |
|
Slide Number 7 |
545 |
|
Slide Number 8 |
546 |
|
Slide Number 9 |
547 |
|
Slide Number 10 |
548 |
|
Slide Number 11 |
549 |
|
Slide Number 12 |
550 |
|
Slide Number 13 |
551 |
|
Slide Number 14 |
552 |
|
Slide Number 15 |
553 |
|
Slide Number 16 |
554 |
|
Slide Number 17 |
555 |
|
Slide Number 18 |
556 |
|
Slide Number 19 |
557 |
|
Slide Number 20 |
558 |
|
Slide Number 21 |
559 |
|
Slide Number 22 |
560 |
|
Slide Number 23 |
561 |
|
Slide Number 24 |
562 |
|
Coupled Cavity Linac |
563 |
|
Slide Number 26 |
564 |
|
Slide Number 27 |
565 |
|
Slide Number 28 |
566 |
|
Slide Number 29 |
567 |
|
Slide Number 30 |
568 |
|
Slide Number 31 |
569 |
|
Slide Number 32 |
570 |
|
Slide Number 33 |
571 |
|
Slide Number 34 |
572 |
|
Slide Number 35 |
573 |
|
L19A_Mazal_OMT |
574 |
|
L19B_Lomax_OM&PBS |
622 |
|
L20_Timmermann_Eye |
632 |
|
L21_De Neve_Liver and GI |
676 |
|
L22A_De Neve_Trial methodology |
722 |
|
L22B_Jäkel_Modelling |
743 |
|
L23A_Peschke_Late toxicity |
752 |
|
L24A_Hug_Breast |
772 |
|
L24B_Jäkel_LET Painting |
800 |
|
L25A_Habrand_ToxicitytoCNS |
807 |
|
L27_Hug_Clin Trials |
866 |
|
L28_Fossati_pancreas rectum |
932 |
|
L29_Krengli_HN&CNS |
1015 |
|
L30_Jäkel_Dosimetry |
1063 |
|
L31_Peschke_Quality matters final |
1087 |
|
L32_Krengli_EB carbon ion therapy |
1158 |
|
L33_Hug_Protons final thoughts |
1177 |
|
L34_Mazal_Photon innovations |
1278 |
|
L35A_Lomax_in favourPT |
1313 |
|
L35B_Jäkel_againstPT |
1356 |
|
EXTRA_Timmermann |
1379 |


